Welcome to our dedicated page for Gardiner Healthcare Acquisitions news (Ticker: GDNRU), a resource for investors and traders seeking the latest updates and insights on Gardiner Healthcare Acquisitions stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Gardiner Healthcare Acquisitions's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Gardiner Healthcare Acquisitions's position in the market.
Gardiner Healthcare Acquisitions Corp. (NASDAQ:GDNRU) announced that effective January 13, 2022, investors can trade shares of common stock and warrants separately from the units sold in its IPO. The common shares will trade under the ticker symbol 'GDNR' and the warrants under 'GDNRW.' The units, if not separated, will continue trading under 'GDNRU.' The offering was underwritten, with Chardan as the sole book-running manager. The SEC declared the registration statement effective on December 21, 2021.
Gardiner Healthcare Acquisitions Corp. (NASDAQ: GDNRU) has successfully issued an additional 1,125,000 units through the full exercise of the underwriters' over-allotment option during its initial public offering (IPO). This issuance generated gross proceeds of $11,250,000, raising the total proceeds from the IPO to $86,250,000. The units began trading on NASDAQ on December 22, 2021, with each unit comprising one share and one warrant, the latter allowing purchase at $11.50 per share. The offering was managed by Chardan, with B. Riley Securities as an independent underwriter.
Gardiner Healthcare Acquisitions Corp. (NASDAQ: GDNRU) announced the closing of its initial public offering (IPO), raising $75 million by offering 7,500,000 units at $10.00 each. Each unit consists of one common stock share and one warrant, which allows the purchase of an additional share at $11.50. The underwriters have a 45-day option to buy an additional 1,125,000 units. The IPO registration statement was effective as of December 21, 2021, and the transaction is directed towards potential mergers in the healthcare sector.
Gardiner Healthcare Acquisitions Corp. (NASDAQ: GDNRU) has announced the pricing of its initial public offering, raising $75 million by offering 7,500,000 units at $10.00 each. Trading will commence on December 22, 2021. Each unit consists of one share of common stock and one warrant, with warrants priced at $11.50 per share. There is an option for underwriters to purchase an additional 1,125,000 units for over-allotments. The offering is expected to close on December 27, 2021, pending customary conditions.
